Cargando…

Neuropathology and molecular diagnosis of Synucleinopathies

Synucleinopathies are clinically and pathologically heterogeneous disorders characterized by pathologic aggregates of α-synuclein in neurons and glia, in the form of Lewy bodies, Lewy neurites, neuronal cytoplasmic inclusions, and glial cytoplasmic inclusions. Synucleinopathies can be divided into t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koga, Shunsuke, Sekiya, Hiroaki, Kondru, Naveen, Ross, Owen A., Dickson, Dennis W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684287/ https://www.ncbi.nlm.nih.gov/pubmed/34922583 http://dx.doi.org/10.1186/s13024-021-00501-z

Ejemplares similares

The neuropathological diagnosis of Alzheimer’s disease
por: DeTure, Michael A., et al.
Publicado: (2019)

Pick’s Disease, Seeding an Answer to the Clinical Diagnosis Conundrum
por: Tamvaka, Nicole, et al.
Publicado: (2023)

Neuropathology and emerging biomarkers in corticobasal syndrome
por: Koga, Shunsuke, et al.
Publicado: (2022)

Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease
por: Tunold, Jon-Anders, et al.
Publicado: (2023)

Neuropathology of Parkinson’s disease after focused ultrasound thalamotomy
por: Koga, Shunsuke, et al.
Publicado: (2022)

Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers
por: Goolla, Meghana, et al.
Publicado: (2023)

The Synucleinopathies: Twenty Years On
por: Goedert, Michel, et al.
Publicado: (2017)

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
por: Valentino, Rebecca R., et al.
Publicado: (2020)

Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration
por: Koga, Shunsuke, et al.
Publicado: (2023)

Neuropathological background of phenotypical variability in frontotemporal dementia
por: Josephs, Keith A., et al.
Publicado: (2011)

Molecular Neuropathology of Gliomas
por: Riemenschneider, Markus J., et al.
Publicado: (2009)

Machine learning‐based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration
por: Koga, Shunsuke, et al.
Publicado: (2021)

Old age amyotrophic lateral sclerosis and limbic TDP‐43 pathology
por: Murakami, Aya, et al.
Publicado: (2022)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies
por: Leys, Fabian, et al.
Publicado: (2021)

Selective vulnerability in α-synucleinopathies
por: Alegre-Abarrategui, Javier, et al.
Publicado: (2019)

Phytochemicals as Regulators of Genes Involved in Synucleinopathies
por: Surguchov, Andrei, et al.
Publicado: (2021)

Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts
por: McKee, Ann C., et al.
Publicado: (2023)

Neurons and Glia Interplay in α-Synucleinopathies
por: Mavroeidi, Panagiota, et al.
Publicado: (2021)

Autophagy in α-Synucleinopathies—An Overstrained System
por: Fellner, Lisa, et al.
Publicado: (2021)

Gaucher disease and the synucleinopathies: refining the relationship
por: Campbell, Tessa N, et al.
Publicado: (2012)

Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
por: Arotcarena, Marie-Laure, et al.
Publicado: (2019)

Mechanisms of Neuronal Death in Synucleinopathy
por: Takeda, Atsushi, et al.
Publicado: (2006)

Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies
por: Ebrahimi-Fakhari, Darius, et al.
Publicado: (2013)

Molecular Neuropathology of TDP-43 Proteinopathies
por: Neumann, Manuela
Publicado: (2009)

Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy(1)
por: Jellinger, Kurt A.
Publicado: (2018)

Leukotriene Signaling as a Target in α-Synucleinopathies
por: Strempfl, Katharina, et al.
Publicado: (2022)

Molecular neuropathology of brain‐invasive meningiomas
por: von Spreckelsen, Niklas, et al.
Publicado: (2022)

Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies
por: Sandoval, Ivette M., et al.
Publicado: (2021)

Sirtuins and Proteolytic Systems: Implications for Pathogenesis of Synucleinopathies
por: Sampaio-Marques, Belém, et al.
Publicado: (2015)

Protein Quality Control Pathways at the Crossroad of Synucleinopathies
por: De Mattos, Eduardo P., et al.
Publicado: (2020)

Surgical Management of Synucleinopathies
por: Sriram, Sai, et al.
Publicado: (2022)

Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy
por: Roemer, Shanu F., et al.
Publicado: (2022)

The molecular neurobiology and neuropathology of opioid use disorder
por: Blackwood, Christopher A., et al.
Publicado: (2021)

Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease
por: Hanna Al-Shaikh, Fadi S., et al.
Publicado: (2019)

Silver diagnosis in neuropathology: principles, practice and revised interpretation
por: Uchihara, Toshiki
Publicado: (2007)

Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures
por: Valentino, Rebecca R., et al.
Publicado: (2022)

The Potential of iPS Cells in Synucleinopathy Research
por: Linta, Leonhard, et al.
Publicado: (2012)

GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
por: Granek, Zuzanna, et al.
Publicado: (2023)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
por: Brás, Inês C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0m6flgf15a3uo2r782h2rhm7dt